Which means dental visits could evolve beyond teeth into early health screening touchpoints
Glucagon-like peptide-1 (GLP-1) agonists, which improve insulin secretion, decrease glucagon secretion, increase satiety (and therefore decrease food intake), and may have beneficial effects on beta-cell function, represent an important addition to treatment options
Some individuals may experience a decline in their mental health while taking Wegovy, which is completely unrelated to the medication
Ongoing post-marketing surveillance and long-term prospective studies will be crucial to further elucidate the neuropsychiatric safety profile of current and emerging incretin-based multi-agonists
Dosage Adjustments Based on Individual Response Individual reactions to Semaglutide can vary
Clinical Results : Participants in STEP trials lost an average of 14.9% body weight over 68 weeks